X
Welcome to the
Bioven website
Our focus in on cancer. We are an immuno oncology company with programs in NSCLC and a pipeline in other indications.

LEARN MORE
News Updates
10 Feb 2017 Pathway Targeted Immunotherapy
15 Dec 2016 Bioven GETS FDA PHASE III LUNG CANCER STUDY APPROVAL.
Bioven GETS FDA PHASE III LUNG CANCER STUDY APPROVAL.